10% OFF SITEWIDE

00h00m00s
use codeAUGUST10stacks on top of bundle savings
side-by-side research comparison

BPC-157 vs CJC-1295 / Ipamorelin

BPC-157 and CJC-1295 / Ipamorelin come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.

✓ both US-made · third-party tested · batch COA on every order

at a glance

BPC-157CJC-1295 / Ipamorelin
compound classSynthetic pentadecapeptide · tissue-repair researchCo-formulated GHRH-analog and secretagogue blend
research arearecovery & gutlongevity & cellular
purity standard99%+ by HPLC99%+ by HPLC
manufacturedUnited StatesUnited States
batch COApublished per lotpublished per lot
price from$99.99$169.49
availabilityin stockin stock

what each one is

BPC-157

Synthetic pentadecapeptide · tissue-repair research

BPC-157 is a synthetic pentadecapeptide, a chain of 15 amino acids, derived from a partial sequence of a protein identified in human gastric juice, sometimes referred to as Body Protection Compound. It is a stable, water-soluble peptide and one of the most frequently cited reference compounds in tissue-repair and cellular research.

full BPC-157 profile →

CJC-1295 / Ipamorelin

Co-formulated GHRH-analog and secretagogue blend

CJC-1295 / Ipamorelin is a co-formulated research blend of two peptides that act at separate receptors. CJC-1295 without DAC, also referred to as Mod GRF 1-29, is a modified 29-amino-acid analog of growth-hormone-releasing hormone characterized as a GHRH-receptor agonist. Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the growth-hormone secretagogue receptor, GHS-R1a.

full CJC-1295 / Ipamorelin profile →

where the research differs

Both compounds are supplied strictly for laboratory research use only. Reported research contexts for each:

BPC-157

  • Cell-migration and wound-healing research models
  • Angiogenesis and vascular signaling research
  • Tendon, ligament, and connective-tissue research models
  • Gastrointestinal-tract research
  • Nitric-oxide pathway studies

CJC-1295 / Ipamorelin

  • Dual-pathway GHRH-receptor and GHS-R1a signaling research
  • Receptor cross-talk and signal-transduction research models
  • Comparative agonist research versus single-component preparations
  • Endocrine-signaling research in cellular and pre-clinical models
  • Peptide stability and analog structure–activity research

shop either compound

Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.

build a stack with both →

frequently asked

What is BPC-157?

BPC-157 is a synthetic 15-amino-acid peptide (a pentadecapeptide) based on a sequence found in human gastric juice. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is BPC-157 studied for in research?

In in-vitro and pre-clinical research it is used as a reference compound in models of tissue repair, angiogenesis, cell migration, and extracellular-matrix remodeling. Verve makes no claims about use in humans or animals.

What is CJC-1295 / Ipamorelin?

It is a co-formulated research blend of CJC-1295 without DAC (also called Mod GRF 1-29), a GHRH analog, and ipamorelin, a selective GHS-R1a agonist. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.

What is the difference between CJC-1295 with and without DAC?

The DAC (drug affinity complex) modification is a chemical addition studied for its effect on the analog's circulating half-life in pre-clinical models. The no-DAC form, Mod GRF 1-29, lacks that modification and is the component used in this blend.

related comparisons

verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.